Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers
There is limited understanding regarding how various e-cigarette flavorings may influence the behavior of non-regular e-cigarette users who are regular cigarette smokers.
To assess differences in nicotine delivery, puffing topography, subjective effects, and user satisfaction from different flavored e-liquids.
Eighteen daily smokers (average age, 44.1 ± 7.0; 9 males; average CPD, 13.0 ± 5.8) smoked their tobacco cigarettes during an initial visit and returned five times to try an e-cigarette (eGo type) refilled with a nicotine solution (24 mg/ml) of five different flavors: cherry, tobacco, espresso, menthol, and vanilla (randomized order). Assessments at each visit included puffing topography, blood samples for nicotine analysis, and subjective reports of nicotine effects and flavor satisfaction.
Vaping different flavors resulted in different levels of plasma nicotine. The flavor producing the highest plasma nicotine concentration (Cmax) was cherry (median 21.2 ng/ml), which was not significantly different than nicotine delivery from a combustible cigarette (29.2 ng/ml, p > .05). Vanilla e-liquid produced the lowest Cmax (9.7 ng/ml), and participants tended to puff less frequently on vanilla compared to tobacco flavor (p = .013). Flavors did not differ significantly in the speed of nicotine delivery (Tmax). During controlled use, puff duration for all flavors was significantly longer than a combustible cigarette (p < 0.05). After controlling for nicotine delivery, significant differences in flavor enjoyment were detected. Menthol flavored e-liquid was rated as more enjoyable than vanilla and tobacco flavored e-liquids (p < 0.05).
Flavors tested in this study yielded different patterns of nicotine delivery and led to differences in reduction in smoking urges.
ClinicalTrials.gov Identifier: #NCT02575885
KeywordsE-cigarettes Flavors Electronic cigarettes Vaping Vaporizers Nicotine
This research was supported in part by NIH NIDA grant R01DA037446 and NCI/FDA U54CA228110, and analytical chemistry resources grants DA012393 and S1ORR026437.
Compliance with ethical standards
Study procedures were approved by the Institutional Review Board at Roswell Park Comprehensive Cancer Center.
Conflicts of interest
MLG has received research grant support from Pfizer and served as a member of the advisory board of Johnson & Johnson. MCM is on the speakers bureau, has served as a consultant to, and has received research support from Pfizer. NLB is a consultant to Pfizer and Achieve Life Sciences and has been a paid expert witness in litigation against tobacco companies. Other authors have no conflicts to declare.
Information and the views and opinions expressed in this presentation are those of the author only and do not necessarily represent the views, official policy, or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies.
- Benowitz NL, Hukkanen J, Jacob P (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Springer, Nicotine psychopharmacology, pp 29–60Google Scholar
- Cantrell J, Huang J, Greenberg M, Willett J, Hair E, Vallone D (2018) History and current trends in the electronic cigarette retail marketplace in the United States: 2010–2016. Nicotine Tob ResGoogle Scholar
- Farsalinos KE, Spyrou A, Stefopoulos C, Tsimopoulou K, Kourkoveli P, Tsiapras D, Kyrzopoulos S, Poulas K, Voudris V (2015) Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci Rep 5:11269CrossRefPubMedCentralGoogle Scholar
- Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL, Pang RD, McBeth JF, Pentz MA, Samet JM, Leventhal AM (2016) Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: application of a novel methodology. Drug Alcohol Depend 168:176–180CrossRefPubMedCentralGoogle Scholar
- Jacob P III, Yu L, Wilson M, Benowitz NL (1991) Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3′, 3′-d2 in humans. Biol Mass Spectrom 20(5):247–252CrossRefPubMedCentralGoogle Scholar
- Jones B, Kenward MG (2014) Design and analysis of cross-over trials. CRC Press Taylor & Francis, GroupGoogle Scholar
- Schneller LM, Bansal-Travers M, Goniewicz ML, McIntosh S, Ossip D, O'Connor RJ (2018) Use of flavored electronic cigarette refill liquids among adults and youth in the US-results from Wave 2 of the Population Assessment of Tobacco and Health Study (2014-2015). PLoS One 13(8):e0202744CrossRefPubMedCentralGoogle Scholar
- Voos N, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, O'Connor RJ, Goniewicz ML (2019) Randomized within-subject trial to evaluate smokers’ initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products. Addiction.Google Scholar
- Wang B-S, Wang X-J, Gong L-K (2009) The construction of a Williams design and randomization in cross-over clinical trials using SAS. J Stat Softw 29(1):1–10Google Scholar